Bill Snyder Archive — Page 46 of 119

October 6, 2020

Bick receives NIH Director’s Early Independence Award

Alexander Bick, MD, PhD, a new faculty member in the Division of Genetic Medicine at Vanderbilt University Medical Center, has received a 2020 National Institutes of Health (NIH) Director’s Early Independence Award.

By Bill Snyder
October 5, 2020

Nominations sought for 2021 Vanderbilt Prize in Biomedical Science

Nominations for the 2021 Vanderbilt Prize in Biomedical Science are now being accepted. The nomination deadline is Dec. 11.

By Bill Snyder
VUMC’s REDCap team helped the Washington State Department of Health ramp up its COVID-19 drive-through testing capabilities. Above, testing is performed in Everett, Washington, in March.
September 24, 2020

REDCap helps state of Washington scale up its testing capacity

Until it was eclipsed by New York in mid-April, the state of Washington had the highest absolute number of COVID-19 cases in the United States.

By Bill Snyder
Cody Siciliano, PhD, is studying the neural substrates of memory.
September 24, 2020

Cohen Fund bolsters Siciliano’s memory research

Cody Siciliano, PhD, assistant professor of Pharmacology in the Vanderbilt University School of Medicine, has been selected to receive a one-year, $100,000 research award from the Stanley Cohen Innovation Fund to support his studies of the neural substrates of memory.

By Bill Snyder
September 18, 2020

The Molecular Infectious Disease Lab team earns spotlight for work on COVID-19 diagnostic testing

The first suspected case of COVID-19 was detected in Tennessee March 5. Within four days, the lab team identified a testing platform, obtained reagents and developed and validated the test.
By the end of the first 10 days, more than 3,300 tests had been completed.

By Bill Snyder
September 17, 2020

Grant from Google to support COVID gene expression study

Vanderbilt University Medical Center and the University of North Carolina (UNC) at Chapel Hill have been awarded $500,000 by Google’s philanthropy, Google.org, to study how COVID-19 alters gene expression in some people in ways that may be linked to their risk of severe illness and death.

By Bill Snyder